Home / Search

Search

9 Search Results

Can MIS-C develop beyond 16 weeks?

Yıldız Ekemen Keleş, Eda Karadağ Öncel, Ahu Kara Aksay, Dilek Yılmaz Çiftdoğan
Full Text PDF HTML
DOI Link

SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center

Betül Sözeri, Ferhat Demir, Sevinç Kalın, Canan Hasbal Akkuş, Enes Salı, Deniz Çakır
Full Text PDF HTML
DOI Link

Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after COVID-19 infection requiring mechanical ventilation

Brona Dinneen, John Stack
Full Text PDF HTML
DOI Link

Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19

Nesrin ŞEN, Mehmet Engin TEZCAN
Full Text PDF HTML
DOI Link

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
Full Text PDF HTML
DOI Link

Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases

Fatih Taştekin, Meltem Taşbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni
Full Text PDF HTML
DOI Link

Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?

Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour
Full Text PDF HTML
DOI Link

The effect of the pandemic on autoantibody rates in the general population

Mehmet Karabey, Havva Kaya, Alperen Ceylan, Kadir Kaba, Mehmet Özdemir, Bahadır Feyzioğlu
Full Text PDF HTML
DOI Link

How do COVID-19 vaccines affect rheumatic diseases?

Lale Altan, Salim Mısırcı, İlker Yağcı, Meltem Karacaatlı, Feyza Ünlü Özkan, Altuğ Güner, İlknur Aktaş
Full Text PDF HTML
DOI Link
1 - 9 of 9 items